开云app官网登录入口网页版-官方正版

#TLR4/MyD88/NF-κB通路#

0篇内容 | 593人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2222090, encodeId=a65b22220906e, content=<a href='/topic/show?id=053d2148601' target=_blank style='color:#2F92EE;'>#中医药#</a> <a href='/topic/show?id=d619e11695c' target=_blank style='color:#2F92EE;'>#痛风性肾病#</a> <a href='/topic/show?id=616b611e9bc' target=_blank style='color:#2F92EE;'>#机制研究#</a> <a href='/topic/show?id=3fdf10941992' target=_blank style='color:#2F92EE;'>#TLR4/MyD88/NF-κB通路#</a> <a href='/topic/show?id=dbcc11824383' target=_blank style='color:#2F92EE;'>#傣痛消#</a>, objectTitle=Front Pharmacol：傣痛消通过TLR4/MyD88/NF-κB通路抑制炎症反应改善痛风性肾病, objectType=article, longId=840337, objectId=be8984033ed4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240814/1723629131170_2570354.jpg, objectUrl=/article/show_article.do?id=be8984033ed4, replyNumber=0, likeNumber=37, createdTime=2024-08-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=be8984033ed4, moduleTitle=Front Pharmacol：傣痛消通过TLR4/MyD88/NF-κB通路抑制炎症反应改善痛风性肾病, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=be8984033ed4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2178087, encodeId=b33521e8087e9, content=<a href='/topic/show?id=98c0553894c' target=_blank style='color:#2F92EE;'>#抗炎#</a> <a href='/topic/show?id=e9846644229' target=_blank style='color:#2F92EE;'>#湿疹#</a> <a href='/topic/show?id=69388e02586' target=_blank style='color:#2F92EE;'>#苦参#</a> <a href='/topic/show?id=de675021419' target=_blank style='color:#2F92EE;'>#当归#</a> <a href='/topic/show?id=3fdf10941992' target=_blank style='color:#2F92EE;'>#TLR4/MyD88/NF-κB通路#</a>, objectTitle=J Ethnopharmacol：苦参—当归通过抑制TLR4/MyD88/NF-κB通路治疗湿疹, objectType=article, longId=807515, objectId=a1e380e51595, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231229/1703864834087_5610093.jpg, objectUrl=/article/show_article.do?id=a1e380e51595, replyNumber=0, likeNumber=135, createdTime=2023-12-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a1e380e51595, moduleTitle=J Ethnopharmacol：苦参—当归通过抑制TLR4/MyD88/NF-κB通路治疗湿疹, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=a1e380e51595)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯管理员

抗炎湿疹苦参当归 TLR4/MyD88/NF-κB通路

2023-12-30发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#中医药# #痛风性肾病# #机制研究# #TLR4/MyD88/NF-κB通路# #傣痛消#

Front Pharmacol：傣痛消通过TLR4/MyD88/NF-κB通路抑制炎症反应改善痛风性肾病

2024-08-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#抗炎# #湿疹# #苦参# #当归# #TLR4/MyD88/NF-κB通路#

J Ethnopharmacol：苦参—当归通过抑制TLR4/MyD88/NF-κB通路治疗湿疹

2023-12-30发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务